Furthermore, stimulation of mitophagy in neurons derived from AD patients reduces hyperphosphorylation of tau protein [84], indicating the crucial role of mitophagy impairments in AD pathogenesis and signifies the need for innovative mitophagy enhancers in AD treatment. The gene discussed is MAPT; the disease is Alzheimer disease.